- Home
- EXAS vs CHKP Comparison
EXAS vs CHKP Comparison
Compare EXAS & CHKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXAS | CHKP |
|---|---|---|
| Founded | 1995 | 1993 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3B | 21.6B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | EXAS | CHKP |
|---|---|---|
| Price | $101.91 | $188.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 24 |
| Target Price | $77.94 | ★ $231.41 |
| AVG Volume (30 Days) | ★ 4.9M | 999.4K |
| Earning Date | 02-18-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.68 |
| EPS | N/A | ★ 9.12 |
| Revenue | ★ $3,082,033,000.00 | $2,684,200,000.00 |
| Revenue This Year | $19.40 | $8.42 |
| Revenue Next Year | $13.51 | $6.04 |
| P/E Ratio | ★ N/A | $20.67 |
| Revenue Growth | ★ 14.47 | 6.31 |
| 52 Week Low | $38.81 | $178.64 |
| 52 Week High | $102.66 | $234.36 |
Technical Indicators
Market Signals| Indicator | EXAS | CHKP |
|---|---|---|
| Relative Strength Index (RSI) | 85.29 | 45.06 |
| Support Level | $101.45 | $187.96 |
| Resistance Level | $102.00 | $190.38 |
| Average True Range (ATR) | 0.39 | 3.47 |
| MACD | -1.26 | -0.08 |
| Stochastic Oscillator | 88.69 | 18.42 |
Price Performance
Historical ComparisonAbout EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About CHKP Check Point Software Technologies Ltd.
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.